Company intelligence / Profile preview

MediLexicon International

Bexhill-on-Sea, England, United Kingdom

Ownership: Private
Employees: ~15
Development stage: Other

Overview

MediLexicon International was a UK-based digital health media and medical information company best known for operating the Medical News Today news site and the MediLexicon medical reference platform. Its business focused on publishing consumer- and professional-facing health and medical news, medical dictionaries, abbreviations, drug and coding databases, and related information services supported by advertising and educational grants. The company was not a drug developer and did not operate a therapeutic pipeline; instead, it functioned as a healthcare content and information platform. MediLexicon International was acquired by Healthline Media in May 2016, with its core assets integrated into Healthline’s broader digital health media network.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on MediLexicon International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MediLexicon International.

Explore the full profile